Risk of Postoperative Complications in Patients Who Underwent Transsphenoidal Pituitary Surgery Treated with Glucagon-Like Peptide Agonists (TRINETX)

Authors

Roger Murayi, Thomas Jefferson UniversityFollow

Publication/Presentation Date

2025

Volume

86

Issue

1

Published In/Presented At

DOI: 10.1055/s-0045-1803739

Disciplines

Medicine and Health Sciences

Department(s)

Department of Surgery

Document Type

Article